Serotonin transporter mRNA expression in the dorsal raphe nucleus of a tumor bearing mouse

Jeong Won Jahng1, Si Ho Choi, Mi Joo Cha

  • 1Department of Pharmacology, BK21 Project for Medical Science, Yonsei University College of Medicine, Seoul 120-752, Korea.

Insights

Oral squamous cell carcinoma significantly decreases serotonin transporter (5-HTT) mRNA in the brain. This may be linked to lower plasma leptin levels in tumor-bearing mice.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Oral squamous cell carcinoma (OSCC) is a prevalent cancer.
  • Serotonin transporter (5-HTT) plays a crucial role in neurotransmission.
  • The central nervous system's response to OSCC is not fully understood.

Purpose of the Study:

  • To investigate the effect of OSCC on central nervous system 5-HTT mRNA expression.
  • To explore the potential correlation between OSCC, 5-HTT levels, and plasma leptin.

Main Methods:

  • Utilized a nude mouse model inoculated with human OSCC (KB cell line).
  • Quantified 5-HTT mRNA expression in the dorsal raphe nucleus (DRN) via in situ hybridization.
  • Measured plasma leptin levels using radioimmunoassay.

Main Results:

  • A significant decrease in 5-HTT mRNA levels was observed in the DRN of tumor-bearing mice compared to controls.
  • Plasma leptin levels were concomitantly reduced in mice with oral tumors.
  • These findings indicate a potential link between OSCC and altered central 5-HTT expression.

Conclusions:

  • Oral squamous cell carcinoma may suppress 5-HTT gene expression in the central nervous system.
  • This suppression might be associated with decreased plasma leptin levels.
  • Further research is warranted to elucidate the precise mechanisms involved.

Related Concept Videos